|Publication number||US20050043763 A1|
|Application number||US 10/958,953|
|Publication date||Feb 24, 2005|
|Filing date||Oct 5, 2004|
|Priority date||Apr 23, 2003|
|Also published as||US7488293, US20040215244, US20060009809, USRE44187, WO2004093651A2, WO2004093651A3|
|Publication number||10958953, 958953, US 2005/0043763 A1, US 2005/043763 A1, US 20050043763 A1, US 20050043763A1, US 2005043763 A1, US 2005043763A1, US-A1-20050043763, US-A1-2005043763, US2005/0043763A1, US2005/043763A1, US20050043763 A1, US20050043763A1, US2005043763 A1, US2005043763A1|
|Inventors||Alan Marcovecchio, Frederick Geheb, Donald Boucher|
|Original Assignee||Zoll Medical Corporation, A Massachusetts Corporation|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (32), Referenced by (35), Classifications (6), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a divisional of U.S. patent application Ser. No. 10/441,933, filed on May 20, 2003, which is a continuation in part of U.S. patent application Ser. No. 10/421,652, entitled “Optical Pulse Sensor for External Defibrillator,” filed on Apr. 23, 2003.
This invention relates to pulse sensors and methods of using pulse sensors in conjunction with external defibrillators.
The pulse is a very important parameter that is used to aid users of automated external defibrillators in determining whether or not to administer a defibrillation shock to and/or to perform cardiopulmonary resuscitation (CPR) on a victim who appears to be in cardiac arrest. Such a victim may actually be in need of cardiac resuscitation (including defibrillation and/or CPR), or may be suffering from a condition for which such treatment would be unsuitable, e.g., a stroke, seizure, diabetic coma, or heat exhaustion. It is very important to the safety of the victim that the presence or absence of a pulse be determined quickly and accurately. However, it is often difficult for trained medical personnel to take a victim's pulse accurately in the field during a crisis situation, and may be impossible for a minimally trained or untrained lay rescuer to do so. In many cases, it will take the person assisting the victim a considerable time (on the order of one minute or more) to find the victim's pulse. If a pulse is not found, the caregiver is left unsure as to whether the victim does not have a pulse, or whether the caregiver simply cannot find the victim's pulse.
Another parameter that is used in determining whether to administer a defibrillation shock is an ECG analysis of the victim's heart rhythm that is provided by the automated external defibrillator. Based on the ECG analysis, many automated defibrillators will provide the user with a message indicating whether a shock should be administered (i.e., whether or not ventricular fibrillation is present).
Generally, the ECG analysis systems in most commercially available automated external defibrillators display only two options to the user: “Shock Advised” or “No Shock Advised.” When “Shock Advised” is output, this means that the patient is in ventricular fibrillation or wide complex ventricular tachycardia above 150 BPM, conditions which are effectively treated by defibrillation. When “No Shock Advised” is output, this means that the patient's heart rhythm is not treatable by defibrillation therapy. If the message indicates that a shock is not appropriate, this does not necessarily mean that the victim is not in danger. There are two ECG rhythms, generally referred to as asystole and pulseless electrical activity, which should not be treated with defibrillation (and thus will trigger a message not to shock) but nonetheless are extremely serious in that they suggest that the patient's heart rhythm is unaccompanied by sufficient cardiac output (i.e., the patient is close to death). These conditions are treated by administering cardiopulmonary resuscitation (CPR), in an effort to provide blood flow to the heart and vital organs in the hope that with improved blood flow and oxygenation, the heart muscle will recover from its near death state and possibly begin to fibrillate again, thus making defibrillation treatment a viable option.
Thus, when a “No Shock Advised” analysis is output, the caregiver does not know whether this result is caused by a normal heart rhythm, an abnormal but perfusing heart rhythm (i.e., the patient was never in cardiac arrest or the last shock treatment returned the patient's heart rhythm to normal), or a grossly abnormal (non-perfusing) ECG rhythm requiring CPR treatment. Because of this uncertainty, the normal medical protocol when “No Shock Advised” is output is to check the patient for a pulse and if no pulse is detected to start CPR. If a pulse is detected, then the patient's heart is effectively pumping blood and neither CPR nor defibrillation is warranted. If the victim does not have a pulse, CPR should be started immediately; if a pulse is present, then CPR should not be administered. Because CPR, even if properly administered, can result in broken ribs or other injury to the victim, it is undesirable to administer CPR if it is not actually necessary. Thus, it is again vitally important that an accurate determination of the presence or absence of a pulse be made by the caregiver.
A similar situation of uncertainty occurs after the third defibrillation shock is delivered in the three-shock protocol recommended by the American Heart Association. In this case, if the patient's fibrillation has not been “cured” after delivery of three shocks, the caregiver is instructed to perform CPR on the patient. Because automated external defibrillators generally do not perform an ECG analysis immediately after the third shock, the caregiver does not know whether the third shock provided effective treatment. Therefore, the caregiver must determine whether the patient has a pulse in order to determine whether CPR is needed or whether the patient is out of danger.
A wide variety of sensors have been employed for pulse detection.
Optical sensors have been used in pulse detection. For example, pulse detectors of the type used for measuring heart rate during exercise typically rely on reflectance or transmission of an infrared light beam. Blood pulsing in the user's capillaries produces a corresponding variation in the absorption of light by capillaries, and that variation produces a pulsation in the output of an optical sensor.
Optical sensors are also widely used in pulse oximetry, in which a measurement is made of the percentage of hemoglobin saturated with oxygen. An optical plethysmographic probe attached to the patient's finger or ear lobe generates light at two wavelengths (e.g., 650 nm and 805 nm). The light is partially absorbed by hemoglobin, by amounts that differ depending on whether or not the hemoglobin is saturated with oxygen. By calculating absorption at the two wavelengths, a pulse oximetry device can compute the proportion of hemoglobin that is saturated (oxygenated).
Acoustic sensors have also been applied to pulse detection. Typically, the acoustic sensor is configured to detect sounds characteristic of a beating heart (e.g., the action of a heart valve). E.g., Joo U.S. Pat. No. 6,440,082. Some acoustic sensors used for pulse detection are based on piezoelectric devices.
Another use of a piezoelectric devices in pulse detection is proposed in U.S. patent application Ser. No. 9/846,673, filed on May 1, 2001. The piezoelectric device detects motion of the surface of the body resulting from the pulse (e.g., motion resulting from blood flowing in a blood vessel beneath the sensor).
The inventors have found that an external defibrillator can be configured to determine whether a patient has a pulse by analyzing the output of a pulse sensor in conjunction with the patient's ECG signal to determine whether a pulse is present. In general the invention features applying electrodes to the chest of the patient, detecting at least one ECG signal from electrodes, applying a pulse sensor (of varying kinds) to the patient, detecting a pulse signal from the pulse sensor, and analyzing the pulse signal in conjunction with the ECG signal to determine whether the patient has a pulse.
Preferred implementations of the invention may incorporate one or more of the following: The pulse rate of the pulse signal may be compared to the pulse rate of the ECG signal. The pulse signal may be processed to isolate the pulsatile component of the signal. The pulse signal may be examined for a peak during a window initiated at the occurrence of an R-wave in the ECG signal. A comparison may be made of the energy in discrete frequency bands of the pulse and the ECG signals. A peak frequency corresponding to the peak of one of the pulse and ECG signals may be determined, and the other of the pulse and ECG signals may be examined for a peak within a frequency band surrounding the peak frequency. A frequency domain transformation of the pulse signal may be processed. The frequency domain transformations of the pulse and ECG signal may be processed. A decision whether to deliver a defibrillation waveform to the patient may be based in part on whether processing of the ECG and pulse signals determines that the patient has a pulse. The defibrillator may be an automatic external defibrillator (AED). The implementation may include the capability to provide the user with prompts for performing CPR, wherein the prompts are dependent at least in part on whether the processing of the pulse signal determines that the patient has a pulse. A determination of whether the patient has a pulse may be undertaken after delivery of the defibrillation waveform, and the user may be informed of the outcome of the determination. The pulse sensor (e.g., an optical plethysmographic sensor) may be mechanically connected to at least one of the defibrillation electrodes. There may be two defibrillation electrodes, each supported on a substrate, and the pulse sensor may be supported on the same substrate. The wires connected to the pulse sensor may be bundled with wires connected to the defibrillation electrodes to form a combined bundle of wires extending from the defibrillator to the electrodes and sensor. The pulse sensor may be mechanically separate from the defibrillation electrodes. In the case of an optical pulse sensor, the sensor may be configured to be attached to the forehead of the patient to the ear lobe, to the nasal septum, to the nasal bridge, or to the finger. In the case of an optical pulse sensor, the sensor may be configured so that its output may also be used for pulse oximetry, or it may be configured so that its output is not useful for pulse oximetry. Determining whether the patient has a pulse may include determining whether the pulse, if present, is correlated with the R-wave of the patient's heart rhythm. A determination whether to administer CPR to the patient may be based on whether it is determined that the patient has a pulse. The pulse sensor may be to determine the efficacy of CPR treatment of the patient. Analyzing the pulse signal in conjunction with the ECG signal may comprise analyzing whether there is a correlation between the two signals indicative of the presence of a pulse.
A wide variety of pulse sensors may be used. The pulse sensor may include a non-optical sensor. The pulse sensor may be an acoustic (heart sounds) sensor. The pulse sensor may include an ultrasonic blood flow sensor. The pulse sensor may include a pressure sensor on a limb-compressing pneumatic cuff. The pulse sensor may include at least one mechanical or ultrasonic sensor (e.g., a piezoelectric sensor) configured to detect arterial wall motion caused by blood flow in an artery. The pulse sensor may include one or more sensors for measuring body impedance variation from blood flow.
Implementations of the invention have many and various advantages. They can make it possible to perform a quick and accurate determination of the appropriate treatment (defibrillation, CPR, or no cardiac-related treatment) for a patient who appears to be suffering from cardiac arrest. They can provide an accurate determination of the presence or absence of a pulse in a patient, even under adverse conditions, thus significantly reducing the risk that an inappropriate and even dangerous treatment will be given erroneously. The accurate pulse determination thus provided relieves the uncertainty experienced by caregivers in the circumstances discussed above, and thus increases the likelihood of the patient receiving prompt, safe and effective treatment. For example, a pulse sensor can be used to determine whether CPR is necessary, in the event that an automated defibrillator indicates that it is not appropriate to shock a patient who appears to be suffering from cardiac arrest.
In some implementations, in which the pulse sensor is an optical sensor, the invention provides an optical sensor without the complexity of pulse oximetry, in which two optical measurements, one at each of two wavelengths, are made, and complex signal processing is performed to estimate blood oxygen saturation from the two measurements.
Other features and advantages of the invention will be apparent from the drawings, detailed description, and claims.
There are a great many possible implementations of the invention, too many to describe herein. Some possible implementations that are presently preferred are described below. It cannot be emphasized too strongly, however, that these are descriptions of implementations of the invention, and not descriptions of the invention, which is not limited to the detailed implementations described in this section but is described in broader terms in the claims.
The descriptions below are more than sufficient for one skilled in the art to construct the disclosed implementations. Unless otherwise mentioned, the processes and manufacturing methods referred to are ones known by those working in the art
The optical plethysmographic sensor 22 detects transmitted or reflected light, and provides a pulse signal 34, which represents a parameter correlated with the patient's pulse. In the case of an optical plethysmographic sensor, the pulse signal 34 would be an optical signal representing the brightness of light transmitted through or reflected from a portion of the body through which blood capillaries extend. The term “pulse signal” is simply a shorthand for an electrical signal representative of a parameter correlated with the pulse of the patient. E.g, in the case of an optical sensor, the pulse signal could be the light sensed by the optical receiver. If the patient has a pulse, there will generally be a pulsing variation in the pulse signal. In the case of an optical sensor, the variation will be in the absorption of light by the blood capillaries.
A variety of signal processing techniques may be used to process the pulse signal to determine whether a pulse is present or absent. Several possibilities are described below. These may be used alone or in combination.
One processing technique is to process the pulse signal 34 to isolate any pulsatile component.
The pulse signal may be filtered so that pulses in the waveform are enhanced and then detected with a beat detection algorithm (e.g., the algorithm conventionally utilized for ECG R-wave detection). The filtering may include a high pass filter, a low pass filter, and also a notch filter to remove line noise if necessary. The high pass filter with a −3 dB cutoff frequency near 0.5 Hz removes any DC component, thus enhancing any existing pulsatile component. The low pass filter, with a −3 dB point in the range of 5-15 Hz removes some signal components unrelated to patients' pulse (i.e., noise). A smoothed or unsmoothed difference operation may also be applied to the pulse signal as one method to enhance or precondition the pulse signal for a time-domain beat detection algorithm.
The beat detection algorithm of
Another processing technique is to use both a pulse signal from the pulse sensor and an ECG signal from the electrodes. Typically, both the pulse signal and the ECG signal will exhibit periodicity when a pulse is present, because a true pulse originates from a mechanically beating heart, and thus the same periodicity observed on the pulse signal should be present on the ECG signal when the heart is beating. However, a periodic ECG signal is not always indicative of a pulse, and thus should only be used to verify (or in combination with) periodicity detected in the pulse signal.
A simpler technique is to determine the pulse rate of each of the ECG and pulse signals, and simply compare the two pulse rates. If the difference between the two rates is within a range (e.g., 1-5 beats/minute), the existence of a pulse is declared. This technique may be used in conjunction with the pulse windowing scheme to minimize the number of false positive detections on the pulse signal. If the implementation does not employ a method (e.g., windowing scheme) to minimize false positive detections on the pulse signal, then the comparison between pulse and ECG derived pulse rates may be modified. In this case the absence of a pulse would be declared if the pulse rate is less than the ECG rate. This modification takes into consideration that the pulse rate may be higher than the ECG rate due to false pulse detections, and such a condition may be indicative of a pulse despite the difference between the two rates being outside of a range.
Another technique is to compare band-limited versions of the ECG and pulse signals. The signals can be band limited over a range of likely pulse frequencies (e.g., 0.5-5 Hz). The band-limited signals are compared to determine if a pulse or peak frequency of the pulse signal compares well with a pulse or peak frequency of the ECG signal. If the two compare well, the existence of a patient pulse is supported. Comparisons can be made using several different quantitative techniques. Cross correlation (convolution) of the two filtered waveforms is one technique that can be used to quantify the comparison of the two waveforms.
One technique for comparing the peak frequencies of the two signals is shown in
The peak frequencies can also be compared by examining one signal for a peak located within a predetermined frequency band centered on the peak frequency of the other signal. For example, as shown in
The autocorrelation of the ECG signal can also be compared with the autocorrelation of the pulse signal. Comparing autocorrelation signals improves the signal to noise ratio and may be particularly useful if the periodic component of the signals is small. The two autocorrelation signals may be compared using a cross-correlation. The comparison determines if the periodicity of the two autocorrelated signals are similar. Similar periodicities support the existence of a pulse.
The addition of a pulse detection system adds significant improvements to automatic and semi-automatic external defibrillators. The addition of a pulse detection system will reduce the number of inappropriate shock advisements. Particularly in cases where patients have a pulse, but have been incorrectly classified by the ECG analysis algorithm as having a shockable rhythm. As shown in the table of
The pulse detection system may also be used to improve the defibrillator system by providing feedback to the rescuer during the administration of CPR. In this scenario, the pulse detection system may be utilized to monitor the effect that chest compressions have on a patients pulse. The detected magnitude and frequency of a pulse by the pulse detection system may be used independently or in conjunction with accelerometer data to aid the rescuer in delivering optimal CPR to the victim. Whereas an accelerometer may be used to measure the rate and depth of delivered chest compressions, a pulse detection system may be used to determine if these chest compressions actually result in the movement of blood thus resulting in a pulse.
A wide variety of pulse sensors may be used. For example, the sensor could be optical or non-optical. It could include an acoustic sensor (e.g., amplified stethoscope signals) for detecting heart sounds characteristic of a beating heart. It could include a sensor capable of mechanical or ultrasonic measurement (e.g., piezoelectric) of arterial wall motion—e.g., in locations such as the neck (carotid arteries), arms (radial and brachial arteries), and legs (femoral artery) where the arteries are relatively close to the surface. It could include an ultrasonic measurement of blood flow (e.g., such as the ultrasonic blood flow detectors used to detect carotid and/or femoral artery stenosis). It could include a pressure sensor that measures variation in the pressure in a limb-compressing pneumatic cuff. The sensor could employ impedance techniques for monitoring blood flow into and out of an arterial bed, e.g., as now used to non-invasively measure pulsatile cardiac output by measuring impedance across the chest. The same approach could be applied to other part of the body where pulsatile blood flow exists.
Both invasive (e.g., direct measurements of a parameter) and non-invasive (indirect measurements of a parameter) sensors can be used The examples given above are generally non-invasive. But invasive sensors could also be used, including, for example, pressure sensors coupled to a patient's vascular pressure via a liquid filled catheter, or intravascular pressure sensors, in which the sensor is incorporated onto the tip of a catheter placed in the vascular system.
Many other implementations of the invention other than those described above are within the invention, which is defined by the following claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3903873 *||May 13, 1974||Sep 9, 1975||Royal Douglas E||Pulse contour measuring instrument|
|US4052979 *||Dec 4, 1975||Oct 11, 1977||Mary Ann Scherr||Jewelry and bracelet heartbeat monitor|
|US4299233 *||Oct 3, 1979||Nov 10, 1981||Lemelson Jerome H||Patient monitoring device and method|
|US4331154 *||Oct 15, 1979||May 25, 1982||Tech Engineering & Design||Blood pressure and heart rate measuring watch|
|US4443730 *||May 12, 1982||Apr 17, 1984||Mitsubishi Petrochemical Co., Ltd.||Biological piezoelectric transducer device for the living body|
|US4722347 *||Jun 8, 1987||Feb 2, 1988||Applied Biometrics, Inc.||Apparatus for measuring cardiac output|
|US4911167 *||Mar 30, 1988||Mar 27, 1990||Nellcor Incorporated||Method and apparatus for detecting optical pulses|
|US5086776 *||Mar 6, 1990||Feb 11, 1992||Precision Diagnostics, Inc.||Apparatus and method for sensing cardiac performance|
|US5409009 *||Mar 18, 1994||Apr 25, 1995||Medtronic, Inc.||Methods for measurement of arterial blood flow|
|US5431685 *||Jul 29, 1994||Jul 11, 1995||Intermedics, Inc.||Implantable medical interventional device with criteria modification to enhance recognition of Tachycardia|
|US5595188 *||Jul 26, 1995||Jan 21, 1997||Flowscan, Inc.||Assembly process for polymer-based acoustic differential-output sensor|
|US5645571 *||Aug 8, 1995||Jul 8, 1997||Survivalink Corporation||Automated external defibrillator with lid activated self-test system|
|US5795300 *||Jun 5, 1995||Aug 18, 1998||Advanced Body Metrics Corporation||Heart pulse monitor|
|US5807267 *||Aug 8, 1995||Sep 15, 1998||Advanced Body Metrics Corporation||Heart pulse monitor|
|US5807268 *||Oct 18, 1996||Sep 15, 1998||Medacoustics, Inc.||Disposable sensing device with contaneous conformance|
|US5827198 *||Nov 21, 1996||Oct 27, 1998||Flowscan, Inc.||Low-cost, disposable, polymer-based, differential output flexure sensor and method of fabricating same|
|US5885222 *||Feb 19, 1997||Mar 23, 1999||Medacoustics, Inc.||Disposable acoustic pad sensors|
|US5913829 *||Feb 19, 1997||Jun 22, 1999||Medacoustics, Inc.||Sensing device for acoustic energy|
|US5991661 *||Oct 17, 1997||Nov 23, 1999||Pacesetter, Inc.||System and method for measuring cardiac activity|
|US6298267 *||Mar 7, 2000||Oct 2, 2001||Intermedics Inc.||Method and apparatus for treatment of cardiac electromechanical dissociation|
|US6304773 *||May 21, 1999||Oct 16, 2001||Medtronic Physio-Control Manufacturing Corp.||Automatic detection and reporting of cardiac asystole|
|US6356785 *||Oct 21, 1998||Mar 12, 2002||Cecily Anne Snyder||External defibrillator with CPR prompts and ACLS prompts and methods of use|
|US6440082 *||Sep 30, 1999||Aug 27, 2002||Medtronic Physio-Control Manufacturing Corp.||Method and apparatus for using heart sounds to determine the presence of a pulse|
|US6487442 *||Apr 28, 2000||Nov 26, 2002||Nicholas Wood||Detection of abnormal and induction of normal heat rate variability|
|US6567697 *||Oct 20, 2000||May 20, 2003||Galvani, Ltd.||External defibrillator with electrical CPR assist|
|US6575914 *||May 18, 2001||Jun 10, 2003||Koninklijke Philips Electronics N.V.||Integrated cardiac resuscitation system with ability to detect perfusion|
|US6591135 *||Apr 16, 2001||Jul 8, 2003||Ge Medical Systems Information Technologies, Inc.||Portable patient monitor with defibrillator/pacemaker interface and battery power management|
|US20010047140 *||Feb 27, 2001||Nov 29, 2001||Freeman Gary A.||Integrated resuscitation|
|US20020165585 *||May 1, 2001||Nov 7, 2002||Dupelle Michael R.||Pulse sensors|
|US20020173725 *||May 18, 2001||Nov 21, 2002||Rock Joseph E.||Integrated cardiac resuscitation system with ability to detect perfusion|
|US20030060723 *||Aug 26, 2002||Mar 27, 2003||Medtronic Physio-Control Manufacturing Corp.||Pulse detection apparatus, software, and methods using patient physiological signals|
|US20040039420 *||Aug 26, 2002||Feb 26, 2004||Medtronic Physio-Control Manufacturing Corp.||Apparatus, software, and methods for cardiac pulse detection using accelerometer data|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7164938||Jun 20, 2005||Jan 16, 2007||Purdue Research Foundation||Optical noninvasive vital sign monitor|
|US7682316||Jul 23, 2007||Mar 23, 2010||Medtronic, Inc.||Implantable heart sound sensor with noise cancellation|
|US7809420||Jul 26, 2006||Oct 5, 2010||Nellcor Puritan Bennett Llc||Hat-based oximeter sensor|
|US7813779||Jul 26, 2006||Oct 12, 2010||Nellcor Puritan Bennett Llc||Hat-based oximeter sensor|
|US7822453||Jul 28, 2006||Oct 26, 2010||Nellcor Puritan Bennett Llc||Forehead sensor placement|
|US7877126||Jul 26, 2006||Jan 25, 2011||Nellcor Puritan Bennett Llc||Hat-based oximeter sensor|
|US7877127||Jul 26, 2006||Jan 25, 2011||Nellcor Puritan Bennett Llc||Hat-based oximeter sensor|
|US7899509||Jul 28, 2006||Mar 1, 2011||Nellcor Puritan Bennett Llc||Forehead sensor placement|
|US8038617||Jul 6, 2006||Oct 18, 2011||Siemens Aktiengesellschaft||Mobile defibrillator|
|US8235911||Oct 3, 2008||Aug 7, 2012||Nellcor Puritan Bennett Ireland||Methods and systems for filtering a signal according to a signal model and continuous wavelet transform techniques|
|US8255029||Feb 27, 2004||Aug 28, 2012||Nellcor Puritan Bennett Llc||Method of analyzing and processing signals|
|US8385675||Oct 10, 2008||Feb 26, 2013||Nellcor Puritan Bennett Ireland||Systems and methods for filtering a signal using a continuous wavelet transform|
|US8388545||Jan 18, 2006||Mar 5, 2013||Cheetah Medical, Inc.||System, method and apparatus for measuring blood flow and blood volume|
|US8414498||May 10, 2004||Apr 9, 2013||Cheetah Medical, Inc.||System, method and apparatus for measuring blood flow and blood volume|
|US8478376||Jul 30, 2009||Jul 2, 2013||Nellcor Puritan Bennett Ireland||Systems and methods for determining physiological information using selective transform data|
|US8523777 *||Apr 15, 2008||Sep 3, 2013||Cheetah Medical, Inc.||Method, apparatus and system for predicting electromechanical dissociation|
|US8600522 *||Aug 15, 2011||Dec 3, 2013||Cardiac Science Corporation||CPR feedback method and apparatus|
|US8764667||Mar 6, 2008||Jul 1, 2014||Cheetah Medical, Inc.||Method and system for monitoring sleep|
|US8790267||Aug 11, 2008||Jul 29, 2014||Cheetah Medical, Inc.||Dynamically variable filter|
|US8876725||Feb 21, 2008||Nov 4, 2014||Cheetah Medical, Inc.||Method and system for estimating exercise capacity|
|US9031627||Oct 1, 2008||May 12, 2015||Nellcor Puritan Bennett Ireland||Signal processing systems and methods using multiple signals|
|US9066691||Oct 3, 2008||Jun 30, 2015||Nellcor Puritan Bennett Ireland||Using a continuous wavelet transform to generate a reference signal|
|US9095271||Aug 13, 2007||Aug 4, 2015||Cheetah Medical, Inc.||Dynamically variable filter|
|US20050283082 *||Jun 20, 2005||Dec 22, 2005||Geddes Leslie A||Optical noninvasive vital sign monitor|
|US20100217140 *||Apr 15, 2008||Aug 26, 2010||Cheetah Medical Ltd.||Method, apparatus and system for predicting electromechanical dissociation|
|US20110301512 *||Dec 8, 2011||Olson Kenneth F||CPF Feedback Method and Apparatus|
|DE102005031642A1 *||Jul 6, 2005||Jan 18, 2007||Siemens Ag||Mobile defibrillator for diagnosing disease condition e.g. myocardial infarction, has imaging ultrasound device that is provided in or at housing, where ultrasound measuring head and measured data processing unit are provided in device|
|DE102005031642B4 *||Jul 6, 2005||May 29, 2008||Siemens Ag||Mobiler Defibrillator|
|EP1859730A1 *||May 15, 2007||Nov 28, 2007||Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.||Sensor for measuring a vital parameter of a living organism|
|EP2314212A1 *||Nov 18, 2008||Apr 27, 2011||Koninklijke Philips Electronics N.V.||Aural heart monitoring apparatus and method|
|WO2007010422A2 *||Jul 5, 2006||Jan 25, 2007||Koninkl Philips Electronics Nv||Apparatus and method for defibrillation with pulse detection using electromagnetic waves|
|WO2008015624A2 *||Jul 27, 2007||Feb 7, 2008||Koninkl Philips Electronics Nv||Cpr coaching device having internal sensor for sensing a physiological characteristic|
|WO2009072024A1 *||Nov 18, 2008||Jun 11, 2009||Koninkl Philips Electronics Nv||Forehead mounted biometric sensor with motion artifact reducing system and method|
|WO2009138902A1 *||May 6, 2009||Nov 19, 2009||Koninklijke Philips Electronics N.V.||Integrated patient monitoring device|
|WO2014209303A1 *||Jun 26, 2013||Dec 31, 2014||Intel Corporation||Detection of a leading stroke risk indicator|
|Cooperative Classification||A61N1/3925, A61N1/39|
|European Classification||A61N1/39C, A61N1/39|
|Nov 15, 2004||AS||Assignment|
Owner name: ZOLL MEDICAL CORPORATION, MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MARCOVECCHIO, ALAN F.;GEHEB, FREDERICK;BOUCHER, DONALD R.;REEL/FRAME:015378/0466;SIGNING DATES FROM 20030630 TO 20030703
Owner name: ZOLL MEDICAL CORPORATION, MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZMD CORPORATION;REEL/FRAME:015376/0073
Effective date: 20031120
|Dec 1, 2004||AS||Assignment|
Owner name: ZMD CORPORATION, DELAWARE
Free format text: RE-RECORD TO CORRECT THE NAME AND ADDRESS OF THE ASSIGNEE, PREVIOUSLY RECORDED ON REEL 015378 FRAME0466, ASSIGNOR CONFIRMS THE ASSIGNMENT OF THE ENTIRE INTEREST.;ASSIGNORS:MARCOVECCHLO, ALAN F.;GEHEB, FREDERICK;BOUCHER, DONALD R.;REEL/FRAME:015415/0621;SIGNING DATES FROM 20030630 TO 20030703
|Dec 28, 2004||AS||Assignment|
Owner name: ZMD CORPORATION, DELAWARE
Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE 1ST INVENTOR S NAME, DOCUMENT PREVIOUSLY RECORDED ON REEL 015415 FRAME 0621;ASSIGNORS:MARCOVECCHIO, ALAN F.;GEHEB, FREDERICK;BOUCHER, DONALD R.;REEL/FRAME:015504/0205;SIGNING DATES FROM 20030630 TO 20030703